Opinion

Despite their commitments to specialisation, large life sciences companies must not neglect the value of sidelined patents, know-how and other intangible assets

06 March 2021

Decision to abolish troubled patent board is the right one, but policymakers should double down on reform

27 February 2021

Being a rule taker does not sit well with American interests nor with those of the wider global patent community. It is time for a change of approach

20 February 2021

The supermajors are not creating big IP stockpiles in green energy, which means there could be opportunities for others

13 February 2021

Continued criticism of biopharma patent owners fails to acknowledge that manufacturing and supply complexities are the real obstacles to mass inoculation around the world

06 February 2021

From new 101 guidelines to PTAB reform and changing the narrative around innovation, America’s now former IP chief built a considerable legacy

29 January 2021

The patent world functions better when its two most powerful players have a constructive, though competitive, relationship

23 January 2021

Recent measures that widen the door to the sector raise concerns over quality

16 January 2021

“I am heartbroken to see this affront to our constitutional electoral process,” the agency’s Director wrote

09 January 2021

A recent report suggests Wall Street is beginning to realise that the rise of intangible assets has thrown a spanner into time-tested valuation models

12 December 2020

As interested parties start to make their plays, there's still plenty of uncertainty around how much the Canadian tech giant's portfolio of assets might go for

04 December 2020

Europe has never been in a better position to set rules the rest of the world must follow

28 November 2020

World’s largest trade pact is not a show-stopper when it comes to IP, but it will bring changes to ASEAN and clouds US ability to set regional agenda

21 November 2020

A recent announcement by the agency will increase transparency but could have several unintended – and potentially troublesome – consequences

14 November 2020

With the former vice-president closing in on election victory, we take a look at how his administration might tackle key patent issues

07 November 2020

Pharma and biotech companies can learn from how strategies are developed in other sectors, but will still have to forge their own paths to meet new challenges

31 October 2020

As the covid-19 pandemic continues to upend education in the US and beyond, there is an opportunity to create a new normal in how IP is taught, says Megan Carpenter, Dean of the Franklin Pierce School of Law

24 October 2020

Xi Jinping made innovation the focus of a speech marking the Special Economic Zone's 40th anniversary. But a more inward focus could spell change for IP strategies

17 October 2020

Law professor Jorge Contreras contends that the policies of many standards organisations can be interpreted as imposing a broad licensing requirement on SEP owners

10 October 2020

An IPBC Connect discussion among leading women in Asia’s patent professions, focusing on equality between the sexes in the region’s major jurisdictions, showed the way forward – but left one Millennial attendee still wanting more

03 October 2020